PHR2050

氨氯地平相关化合物A

Pharmaceutical Secondary Standard; Certified Reference Material

• 别名: 3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate] fumarate
• 经验公式（希尔记法）: C₂₀H₂₃ClN₂O₅ · C₄H₄O₄
• CAS号: 2138811-33-1
• 分子量: 522.93
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: certified reference material; pharmaceutical secondary standard
• 品質等級: 300
• agency: traceable to USP 1029512
• API 家族: amlodipine
• CofA: current certificate can be downloaded
• 包裝: pkg of 50 mg
• 應用: pharmaceutical small molecule
• 形式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: Clc1c(cccc1)c2c(c(nc(c2C(=O)OC)C)COCCN)C(=O)OCC.OC(=O)\C=C\C(=O)O
• InChI 密鑰: BWAQLJHPVPAANJ-WLHGVMLRSA-N

说明

一般說明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

It is an impurity of the long-acting calcium channel blocker, amlodipine, that belongs to the class of 1,4-Dihydropyridine (DHP) calcium antagonists. The parent active pharmaceutical ingredient is used in the treatment of hypertension and anginal chest pain.[1]

應用

This pharmaceutical secondary standard can also be used as follows:

• Development of a stability-indicating reverse-phase ultra-performance liquid chromatographic (RP-UPLC) method for determining related impurities of S(−)amlodipine and S(−)metoprolol succinate in their combined tablet dosage[1]
• Ultra-high pressure liquid chromatographic (UHPLC) separation and estimation of amlodipine and bisoprolol-related impurities in the combined pharmaceutical formulation of the parent APIs[2]
• Development and validation of a UHPLC method for quantifying impurities of valsartan, amlodipine besylate, and hydrochlorothiazide in their combined tablet dosage
• Separation and determination of amlodipine and atorvastatin, along with their impurities using a stability-indicating RP-HPLC method in their combined solid dosage forms[3]

分析報告

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

腳註

To see an example of a Certificate of Analysis for this material enter LRAB9841 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

推薦產品

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

安全信息

• 象形圖: GHS06,GHS08,GHS05,GHS09
• 訊號詞: Danger
• 危險聲明: H301,H318,H373,H410
• 防範說明: P260 - P273 - P280 - P301 + P310 - P305 + P351 + P338 - P314
• 危險分類: Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - STOT RE 2
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable